Semaglutide Shortage 2025. And now, novo nordisk has taken a step that could signal semaglutide, the key ingredient in ozempic and wegovy, could soon come off the fda shortage list, too. Exceeds the available supply, and that while.
Shortages of injectable semaglutide (novo nordisk), sold under trade names ozempic (for type 2 diabetes with or without established cvd) and wegovy (for overweight or. Exceeds the available supply, and that while.